Platelet-activating factor and the production of human interferon-γ

Journal of Interferon and Cytokine Research

Volumn 17, Issue 2, 1997, Pages 107-112

  Yousefi, S ^a   Vaziri, N ^a   Carandang, G ^a   Villanueva, J LeC ^a   Khonsari, S ^a   Ocariz, J ^a   Cesario, T C ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 2; MESSENGER RNA; PHYTOHEMAGGLUTININ; THROMBOCYTE ACTIVATING FACTOR;

ARTICLE; CONCENTRATION RESPONSE; HUMAN; HUMAN CELL; IMMUNOPATHOGENESIS; IMMUNOSTIMULATION; INTERFERON PRODUCTION; PRIORITY JOURNAL; PROTEIN SYNTHESIS REGULATION; SEPSIS;

EID: 0031053279     PISSN: 10799907     EISSN: None     Source Type: Journal    
DOI: 10.1089/jir.1997.17.107     Document Type: Article

References (22)

1. KOLTAI, M., HOSFORD, D., GUINOT, P., ESANU, A., and BRAQUET, P. (1991). Platelet-activating factor (PAF): A review of its effects, antagonists and possible future clinical applications. Drugs 42, 9-29; 174-204.
2. VENABLE, M., ZTMMERMAN, G., McINTYRE, T., and PRESCOTT, S. (1993). Platelet-activating factor: A phospholipid antacoid with diverse actions. J. Lipid Res. 34, 691-702.
3. 2 production, spreading and the influence of the calmodulin inhibitor W-7. FEBS Lett. 160, 209-212.
4. ADAMS, D.O. (1992). Regulation of macrophage function by interferon gamma In: Interferon: Principles and Medical Applications. S. Baron, D. Coppenhaven, F. Dianzani, W. Fleischman, T. Hughes, G. Klimpel, D. Niesel, G. Stanton, and S. Tyring (eds). Galveston, TX: The University of Texas Medical Branch at Galveston.
5. ANDERSON, B., BONSARD, D., and HARKEN, A. (1991). The role of platelet-activating factor and its antagonists in shock, sepsis and multiple organ failure. Surg. Gynecol. Obstet. 172, 415-424.
6. HEINZEL, F. (1990). The role of gamma Interferon in the pathology of experimental endotoxemia. J. Immunol. 145, 2920-2924.
7. EPSTEIN, L., CLINE, H., and MENGAN, T. (1971). Interaction of human macrophages and lymphocytes in the phytohemagglutinin-stimulated production of interferon. J. Clin. Invest 50, 744-753.
8. 4 and PAF in the cytokine network. In: Cell- Cell Interaction in the Release of Inflammatory Mediators. P.Y.K. Weng and ON. Berhan (eds.) New York: Plenum Press.
9. TORLEY, L., PICKETT, W., CARROL, M., KOHLER, C., SCHAUB, R., WISSNER, A., DE JOY, S., ORONSKY, A., and KERWAR, S. (1992). Studies of the effect of platelet-activating factor antagonist CL 184,005 in animal models of gram-negative bacterial sepsis. Antimicrob. Agents Chemother. 36, 1971-1977.
10. BOYUM, A. (1969). Isolation of mononuclear cells and granulocytes from human blood. J. Clin. Invest. 97 (Suppl), 77-89.
11. WEIDENBACH, A., and HAMPTER, J. (1979). The platelets: A special laboratory problem. In: Laboratory Medicine. G.J. Race (ed.) New York: Harper and Row.
12. CESARID, T., SLATER, L., KAPLAN, H., GUPTA, S., and CORSE, G. (1984). The effect of antineoplastic agents on the production of gamma interferon by human peripheral blood mononuclear cells. Cancer Res. 44, 4962-4967.
13. VAZIRI, N.D., WANG, J., CESARIO, T., YOUSEFI, S., VALENZUELA, R., and CARANDANG, G. (1994). Induction, transcription, synthesis and absorption of IL1 by dialyzer membranes in a murine macrophage cell line. Am. J. Nephrol. 4, 1884-1889.
14. BONE, R. (1991). The pathogenesis of sepsis. Ann. Intern. Med. 115, 457-469.
15. POUBELLE, P., GINGRAS, D., DEMAIS, C., DUBROS, C., HARBOUR, D., and ROLA-PLESZCYNSKI, M. (1991). Platelet-activating factor (PAF-acether) enhances the concomitant production of tumor necrosis factor alpha and interleukin 1 by a subset of human monocytes. Immunology 72, 181-187.
16. BARRETT, M., LEWIS, G., WARD, S., and WESTWICK, J. (1987). Platelet-activating factor induces interleukin 1 production from human adherent macrophages. Br. J. Pharmacol. 90:113P.
17. SALEM, P., DERICKX, S., DULIOUST, A., VIVIER, E., DENIZOT, E., DAMAIS, C., DINARELLO, C., and THOMAS, Y. (1990). Immunoregulatory functions of PAF-acether. Enhancement of IL-1 production by muramyl dipeptide stimulated monocytes. J. Immunol. 144, 1338-1344.
18. ROLA-PLESZCYNSKI, M., BOUVELTE, M., THIVAGE, M., and LACASSE, C. (1990). Platelet-activating factor enhances interleukin 6 production by monocytes, alveolar macrophages and endothelial cells. FASEB J. 4, A1713.
19. BONAVIDA, B., MENAE-HUERTA, J., and BRAGUET, B. (1990). Effects of platelet-activating factor on peripheral blood monocytes: Induction and priming for TNF secretion. J. Lipid Mediators 2, 565-576.
20. ROLA-PLESZCZYNSKI, M., PIGROL, B., POULIOT, C., and BRAQUET, P. (1987). Inhibition of human lymphocyte proliferation and interleukin 2 production by platelet-activating factor (PAF acether): Reversal by a specific antagonist BN 52021. Biochem. Biophys. Res. Commun. 142, 754-760.
21. NABORS, G., and TARLETON, R. (1991). Differential control of Interferon gamma and IL-2 production during Trypanosoma cruzii infection. J. Immunol. 146, 3591-3598.
22. DOHERTY, G., LANGE, R., LANGSTEIN, H., ALEXANDER, H., BURASIN, C., and NORTON, J. (1992). Evidence of interferon gamma as a mediator of the lethality of endotoxin and tumor necrosis factor alpha. J. Immunol. 149, 1666-1670.